In this episode we discuss a paper published in the Lancet which compares the effectiveness and costs of 7-day versus 4-day infusion set replacement to prevent CRBSI with lead author Professor Claire Rickard. Professor Rickard is a Professor of Infection Prevention & Vascular Access at the University of Queensland. Claire established the Alliance for Vascular Access Teaching and Research (AVATAR) in 2007 as an investigator network to promote high quality work in the field of vascular access.

Link to the publication: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00351-2/fulltext